Response by van Doorn et al to Letters Regarding Article, "Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial"

被引:0
|
作者
van Doorn, Sander [1 ]
Rutten, Frans H. [1 ]
Geersing, Geert-Jan [1 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Primary Care & Nursing Sci, Utrecht, Netherlands
关键词
EFFICACY; WARFARIN; PREVENTION; STROKE;
D O I
10.1161/CIRCULATIONAHA.124.070172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e30 / e32
页数:3
相关论文
共 50 条
  • [31] Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease
    Moon, I. K.
    Lee, S. R.
    Choi, E. K.
    Lee, E. J.
    Jung, J. H.
    Han, K. D.
    Cha, M. J.
    Oh, S. I.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2984 - 2984
  • [32] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Violi, Francesco
    Pastori, Daniele
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (08) : 1199 - 1201
  • [33] Changes in renal function in patients with atrial fibrillation: Efficacy and safety of the non-vitamin K antagonist oral anticoagulants
    Miyazawa, Kazuo
    Pastori, Daniele
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2018, 198 : 166 - 168
  • [34] Effectiveness and Safety of Off-label Dosing of Non-vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
    Lee, Kwang-No
    Choi, Jong-Il
    Boo, Ki Yung
    Kim, Do Young
    Kim, Yun Gi
    Oh, Suk-Kyu
    Baek, Yong-Soo
    Lee, Dae In
    Roh, Seung-Young
    Shim, Jaemin
    Kim, Jin Seok
    Kim, Young-Hoon
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [35] Real-world efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Francesco Violi
    Daniele Pastori
    Internal and Emergency Medicine, 2019, 14 : 1199 - 1201
  • [36] Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
    Gorczyca, Iwona
    Jelonek, Olga
    Uzieblo-Zyczkowska, Beata
    Chrapek, Magdalena
    Maciorowska, Malgorzata
    Wojcik, Maciej
    Blaszczyk, Robert
    Kaplon-Cieslicka, Agnieszka
    Gawalko, Monika
    Budnik, Monika
    Tokarek, Tomasz
    Rajtar-Salwa, Renata
    Bil, Jacek
    Wojewodzki, Michal
    Szpotowicz, Anna
    Bednarski, Janusz
    Bakula-Ostalska, Elwira
    Tomaszuk-Kazberuk, Anna
    Szyszkowska, Anna
    Welnicki, Marcin
    Mamcarz, Artur
    Wozakowska-Kaplon, Beata
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 14
  • [37] Non-vitamin K antagonist oral anticoagulant discontinuation in non-valvular atrial fibrillation patients (ASPECT-NOAC)
    Asilturk, E.
    Tulmac, M.
    Badak, O.
    Onal, T.
    Aras, D.
    Aciksari, G.
    Alper, A. T.
    Celik, A.
    Katicibasi, T.
    Ozdogan, O.
    EUROPEAN HEART JOURNAL, 2021, 42 : 576 - 576
  • [38] Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
    Kim, Hyue Mee
    Choi, Eue-Keun
    Park, Chan Soon
    Cha, Myung-Jin
    Lee, Seo-Young
    Kwon, Joon-Myung
    Oh, Seil
    PLOS ONE, 2019, 14 (03):
  • [39] The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation
    Asuncion Esteve-Pastor, Mario
    Roldan, Vanessa
    Valdes, Mariano
    Lip, Gregory Y. H.
    Marin, Francisco
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2016, 14 (02) : 177 - 187
  • [40] The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation A PRISMA-compliant article
    Liu, Xuyang
    Huang, Manxiang
    Ye, Caisheng
    Zeng, Junquan
    Zeng, Changai
    Ma, Jianyong
    MEDICINE, 2020, 99 (27)